SONOMA PHARMACEUTICALS, INC. Deferred Income Tax Expense (Benefit)
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Deferred Income Tax Expense (Benefit) of $244.00 thousand for the 12-month period ending 2026-03-31, per its 10-K filed 2026-06-16.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-06-16
- SONOMA PHARMACEUTICALS, INC. deferred income tax expense (benefit) for the quarter ending 2024-03-31 was $104.00K, a 50.71% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. deferred income tax expense (benefit) for the quarter ending 2023-12-31 was -$52.00K.
- SONOMA PHARMACEUTICALS, INC. deferred income tax expense (benefit) for the quarter ending 2023-09-30 was $54.00K.
- SONOMA PHARMACEUTICALS, INC. deferred income tax expense (benefit) for the quarter ending 2023-06-30 was $90.00K.
- SONOMA PHARMACEUTICALS, INC. deferred income tax expense (benefit) for fiscal 2026 was $244.00K.
- SONOMA PHARMACEUTICALS, INC. deferred income tax expense (benefit) for fiscal 2025 was -$550.00K, a 380.61% decline from fiscal 2024.
- SONOMA PHARMACEUTICALS, INC. deferred income tax expense (benefit) for fiscal 2024 was $196.00K.
- SONOMA PHARMACEUTICALS, INC. deferred income tax expense (benefit) for fiscal 2023 was -$33.00K.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|
| 2026-03-31 | $244.00K 10-K · filed 2026-06-16 | ||||
| 2025-03-31 | -$550.00K 10-K · filed 2026-06-16 | ||||
| 2024-03-31 | $104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-17 | $52.00K derived: sum of 2 quarters · filed 2025-06-17 | $106.00K derived: sum of 3 quarters · filed 2025-06-17 | $196.00K 10-K · filed 2025-06-17 | -$196.00K 10-K · filed 2024-06-17 |
| 2023-12-31 | -$52.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-08 | $2.00K derived: sum of 2 quarters · filed 2024-02-08 | $92.00K 10-Q · filed 2024-02-08 | $303.00K derived: sum of 4 quarters · filed 2024-06-17 | |
| 2023-09-30 | $54.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-13 | $144.00K 10-Q · filed 2023-11-13 | $355.00K derived: sum of 3 quarters · filed 2024-06-17 | $250.00K derived: sum of 4 quarters · filed 2024-06-17 | |
| 2023-06-30 | $90.00K 10-Q · filed 2023-08-10 | $301.00K derived: sum of 2 quarters · filed 2024-06-17 | $196.00K derived: sum of 3 quarters · filed 2024-06-17 | $97.00K derived: sum of 4 quarters · filed 2024-06-17 | |
| 2023-03-31 | $211.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-17 | $106.00K derived: sum of 2 quarters · filed 2024-06-17 | $7.00K derived: sum of 3 quarters · filed 2024-06-17 | -$33.00K 10-K · filed 2024-06-17 | |
| 2022-12-31 | -$105.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-08 | -$204.00K derived: sum of 2 quarters · filed 2024-02-08 | -$244.00K 10-Q · filed 2024-02-08 | ||
| 2022-09-30 | -$99.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-13 | -$139.00K 10-Q · filed 2023-11-13 | |||
| 2022-06-30 | -$40.00K 10-Q · filed 2023-08-10 | ||||
| 2022-03-31 | -$332.00K 10-K · filed 2023-06-21 | ||||
| 2021-03-31 | $942.00K 10-K · filed 2022-07-13 | ||||
| 2020-03-31 | $121.00K 10-K · filed 2021-07-14 | ||||
| 2019-03-31 | $458.00K 10-K · filed 2020-07-10 | ||||
| 2018-03-31 | $50.00K 10-K · filed 2019-07-01 | ||||
| 2017-03-31 | -$4.27M 10-K · filed 2018-06-26 | ||||
| 2016-03-31 | $2.00K 10-K · filed 2017-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |